loading

Kalaris Therapeutics Inc Borsa (KLRS) Ultime notizie

pulisher
08:00 AM

Kalaris Therapeutics Appoints New CFO Matthew Gall - TipRanks

08:00 AM
pulisher
07:44 AM

Kalaris Therapeutics appoints Matthew Gall as chief financial officer By Investing.com - Investing.com UK

07:44 AM
pulisher
07:37 AM

Kalaris Expands Leadership Team Appointing Matthew Gall, MBA, as Chief Financial Officer - The Manila Times

07:37 AM
pulisher
07:30 AM

Kalaris (KLRS) names Matthew Gall CFO amid Phase 1b/2 nAMD study enrollment - Stock Titan

07:30 AM
pulisher
06:16 AM

Will Kalaris Therapeutics Inc. outperform the marketPortfolio Return Summary & Real-Time Volume Analysis Alerts - newser.com

06:16 AM
pulisher
05:44 AM

Can Kalaris Therapeutics Inc. rally from current levelsJuly 2025 Analyst Calls & Community Verified Watchlist Alerts - newser.com

05:44 AM
pulisher
05:37 AM

What to expect from Kalaris Therapeutics Inc. in the next 30 daysWatch List & Real-Time Volume Trigger Notifications - newser.com

05:37 AM
pulisher
03:42 AM

Tools to assess Kalaris Therapeutics Inc.’s risk profileQuarterly Growth Report & Real-Time Market Sentiment Reports - newser.com

03:42 AM
pulisher
03:28 AM

Can trapped investors hope for a rebound in Kalaris Therapeutics Inc.July 2025 Levels & Reliable Momentum Entry Alerts - newser.com

03:28 AM
pulisher
02:52 AM

Citizens initiates Kalaris stock with Market Outperform rating, $20 price target - Investing.com

02:52 AM
pulisher
Nov 02, 2025

Short Interest in Kalaris Therapeutics Inc. (NASDAQ:KLRS) Declines By 40.5% - MarketBeat

Nov 02, 2025
pulisher
Nov 02, 2025

How resilient is Kalaris Therapeutics Inc. stock in market downturnsTrade Performance Summary & Safe Swing Trade Setups - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

How Kalaris Therapeutics Inc. stock performs in rate cut cyclesWeekly Trend Report & Consistent Income Trade Ideas - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

What MACD and RSI say about Kalaris Therapeutics Inc.Weekly Market Summary & Expert-Curated Trade Recommendations - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Is Kalaris Therapeutics Inc. stock positioned for digital transformationWatch List & Fast Entry Momentum Alerts - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Analyzing Kalaris Therapeutics Inc. with risk reward ratio chartsJuly 2025 Sector Moves & Consistent Profit Trade Alerts - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

How to use a screener to detect Kalaris Therapeutics Inc. breakoutsJuly 2025 WrapUp & Weekly Watchlist of Top Performers - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Kalaris Therapeutics Inc. stock outlook for YEAR2025 Performance Recap & Community Verified Watchlist Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Published on: 2025-10-31 05:04:53 - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Identifying reversal signals in Kalaris Therapeutics Inc.Weekly Earnings Recap & Low Risk Investment Opportunities - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Kalaris to Present at Stifel 2025 Annual Healthcare Conference - Investing News Network

Oct 30, 2025
pulisher
Oct 30, 2025

Kalaris (Nasdaq: KLRS) to present at Stifel Healthcare Conference; CEO & CMO 3:20–3:50 ET - Stock Titan

Oct 30, 2025
pulisher
Oct 30, 2025

Leading vs lagging indicators on Kalaris Therapeutics Inc. performance2025 AllTime Highs & Safe Capital Growth Tips - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Published on: 2025-10-30 01:28:32 - newser.com

Oct 30, 2025
$37.52
price up icon 0.03%
$93.16
price down icon 0.32%
$28.84
price up icon 0.79%
$104.30
price up icon 0.20%
biotechnology ONC
$313.33
price up icon 0.97%
$184.11
price down icon 2.65%
Capitalizzazione:     |  Volume (24 ore):